NYSEAMERICAN:EMANeMagin Stock Price, Forecast & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for eMagin in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for eMagin.

eMagin is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020.
View our earnings forecast for eMagin.

eMagin Co. (NYSEAMERICAN:EMAN) released its quarterly earnings data on Thursday, May, 14th. The semiconductor company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The semiconductor company had revenue of $6.73 million for the quarter. During the same quarter in the prior year, the company earned ($0.03) EPS.
View eMagin's earnings history.

eMagin issued an update on its second quarter 2020 Pre-Market earnings guidance on Tuesday, July, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $7.4-7.7 million, compared to the consensus revenue estimate of $7.5 million.

Media stories about EMAN stock have trended negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. eMagin earned a daily sentiment score of -2.9 on InfoTrie's scale. They also assigned media coverage about the semiconductor company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.
View the latest news about eMagin.

eMagin saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 2,400,000 shares, an increase of 29.0% from the June 15th total of 1,860,000 shares. Based on an average trading volume of 4,490,000 shares, the short-interest ratio is presently 0.5 days. Approximately 5.6% of the shares of the company are short sold.
View eMagin's Current Options Chain.

Some companies that are related to eMagin include Manz (M5Z), Nanoco Group (NANO), CML Microsystems (CML), Revasum Cdi 1:1 US Prohibited (RVS), Trio-Tech International (TRT), BluGlass (BLG), Aixtron (AIXXF), Asahi Group (ASMVF), Chow Tai Fook Jewellery Group (ASMVY), Meyer Burger Technology (MYBUF), Nanoco Group (NNOCF), Nordic Semiconductor ASA (NDCVF), Premier Power Renewable Energy (RNWEF), Solitron Devices (SODI) and Terrascend (TER).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other eMagin investors own include Guyana Goldfields (GUY), Hawkins (HWKN), CA (CA), Kopin (KOPN), Universal Display (OLED), BlackRock (BLK), Gold Standard Ventures (GSV), Gold Standard Ventures (GSV), Ampio Pharmaceuticals (AMPE) and Baytex Energy (BTE).

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

Shares of EMAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of EMAN stock can currently be purchased for approximately $1.06.

eMagin has a market capitalization of $64.89 million. eMagin employs 103 workers across the globe.

The official website for eMagin is www.emagin.com.

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The semiconductor company can be reached via phone at +1-845-8387900.